Copeptin Reflect Left Ventricular Systolic Function at Early Stage of Acute Myocardial Infarction in a Pig Model
CONCLUSION: Serum copeptin levels change in time, and measurements at 3 to 6 hours after AMI had the highest predictive value.PMID:37151758 | PMC:PMC10155031 | DOI:10.1177/11772719231171764 (Source: Biomarker Insights)
Source: Biomarker Insights - May 8, 2023 Category: General Medicine Authors: Wenjia Li Wenjian Sun Liang Lyu Gang Wang Weixin Yang Hongfei An Liling Chen Jianhui Fan Yan Yue Rongshun Zhang Source Type: research
The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
CONCLUSION: Various categories of biomarkers including safety, predictive, pharmacodynamic/response, and diagnostic biomarkers are being investigated for potential use in pharmacovigilance. The most frequent potential uses of biomarkers in pharmacovigilance in the literature were the prediction of the severity of an ADR, mortality, response, safety, and toxicity. The safety biomarkers identified were used to evaluate patient safety during dose escalation, identify patients who may benefit from further biomarker testing during treatment, and monitor ADRs.PMID:37077840 | PMC:PMC10108426 | DOI:10.1177/11772719231164528 (Sourc...
Source: Biomarker Insights - April 20, 2023 Category: General Medicine Authors: Maribel Salas Maxine Gossell-Williams Priyanka Yalamanchili Sameer Dhingra Marina A Malikova Omar Aimer Toluwalope Junaid Source Type: research
The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
CONCLUSION: Various categories of biomarkers including safety, predictive, pharmacodynamic/response, and diagnostic biomarkers are being investigated for potential use in pharmacovigilance. The most frequent potential uses of biomarkers in pharmacovigilance in the literature were the prediction of the severity of an ADR, mortality, response, safety, and toxicity. The safety biomarkers identified were used to evaluate patient safety during dose escalation, identify patients who may benefit from further biomarker testing during treatment, and monitor ADRs.PMID:37077840 | PMC:PMC10108426 | DOI:10.1177/11772719231164528 (Sourc...
Source: Biomarker Insights - April 20, 2023 Category: General Medicine Authors: Maribel Salas Maxine Gossell-Williams Priyanka Yalamanchili Sameer Dhingra Marina A Malikova Omar Aimer Toluwalope Junaid Source Type: research
The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
CONCLUSION: Various categories of biomarkers including safety, predictive, pharmacodynamic/response, and diagnostic biomarkers are being investigated for potential use in pharmacovigilance. The most frequent potential uses of biomarkers in pharmacovigilance in the literature were the prediction of the severity of an ADR, mortality, response, safety, and toxicity. The safety biomarkers identified were used to evaluate patient safety during dose escalation, identify patients who may benefit from further biomarker testing during treatment, and monitor ADRs.PMID:37077840 | PMC:PMC10108426 | DOI:10.1177/11772719231164528 (Sourc...
Source: Biomarker Insights - April 20, 2023 Category: General Medicine Authors: Maribel Salas Maxine Gossell-Williams Priyanka Yalamanchili Sameer Dhingra Marina A Malikova Omar Aimer Toluwalope Junaid Source Type: research
The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
CONCLUSION: Various categories of biomarkers including safety, predictive, pharmacodynamic/response, and diagnostic biomarkers are being investigated for potential use in pharmacovigilance. The most frequent potential uses of biomarkers in pharmacovigilance in the literature were the prediction of the severity of an ADR, mortality, response, safety, and toxicity. The safety biomarkers identified were used to evaluate patient safety during dose escalation, identify patients who may benefit from further biomarker testing during treatment, and monitor ADRs.PMID:37077840 | PMC:PMC10108426 | DOI:10.1177/11772719231164528 (Sourc...
Source: Biomarker Insights - April 20, 2023 Category: General Medicine Authors: Maribel Salas Maxine Gossell-Williams Priyanka Yalamanchili Sameer Dhingra Marina A Malikova Omar Aimer Toluwalope Junaid Source Type: research
The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
CONCLUSION: Various categories of biomarkers including safety, predictive, pharmacodynamic/response, and diagnostic biomarkers are being investigated for potential use in pharmacovigilance. The most frequent potential uses of biomarkers in pharmacovigilance in the literature were the prediction of the severity of an ADR, mortality, response, safety, and toxicity. The safety biomarkers identified were used to evaluate patient safety during dose escalation, identify patients who may benefit from further biomarker testing during treatment, and monitor ADRs.PMID:37077840 | PMC:PMC10108426 | DOI:10.1177/11772719231164528 (Sourc...
Source: Biomarker Insights - April 20, 2023 Category: General Medicine Authors: Maribel Salas Maxine Gossell-Williams Priyanka Yalamanchili Sameer Dhingra Marina A Malikova Omar Aimer Toluwalope Junaid Source Type: research
The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
CONCLUSION: Various categories of biomarkers including safety, predictive, pharmacodynamic/response, and diagnostic biomarkers are being investigated for potential use in pharmacovigilance. The most frequent potential uses of biomarkers in pharmacovigilance in the literature were the prediction of the severity of an ADR, mortality, response, safety, and toxicity. The safety biomarkers identified were used to evaluate patient safety during dose escalation, identify patients who may benefit from further biomarker testing during treatment, and monitor ADRs.PMID:37077840 | PMC:PMC10108426 | DOI:10.1177/11772719231164528 (Sourc...
Source: Biomarker Insights - April 20, 2023 Category: General Medicine Authors: Maribel Salas Maxine Gossell-Williams Priyanka Yalamanchili Sameer Dhingra Marina A Malikova Omar Aimer Toluwalope Junaid Source Type: research
The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
CONCLUSION: Various categories of biomarkers including safety, predictive, pharmacodynamic/response, and diagnostic biomarkers are being investigated for potential use in pharmacovigilance. The most frequent potential uses of biomarkers in pharmacovigilance in the literature were the prediction of the severity of an ADR, mortality, response, safety, and toxicity. The safety biomarkers identified were used to evaluate patient safety during dose escalation, identify patients who may benefit from further biomarker testing during treatment, and monitor ADRs.PMID:37077840 | PMC:PMC10108426 | DOI:10.1177/11772719231164528 (Sourc...
Source: Biomarker Insights - April 20, 2023 Category: General Medicine Authors: Maribel Salas Maxine Gossell-Williams Priyanka Yalamanchili Sameer Dhingra Marina A Malikova Omar Aimer Toluwalope Junaid Source Type: research
The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
CONCLUSION: Various categories of biomarkers including safety, predictive, pharmacodynamic/response, and diagnostic biomarkers are being investigated for potential use in pharmacovigilance. The most frequent potential uses of biomarkers in pharmacovigilance in the literature were the prediction of the severity of an ADR, mortality, response, safety, and toxicity. The safety biomarkers identified were used to evaluate patient safety during dose escalation, identify patients who may benefit from further biomarker testing during treatment, and monitor ADRs.PMID:37077840 | PMC:PMC10108426 | DOI:10.1177/11772719231164528 (Sourc...
Source: Biomarker Insights - April 20, 2023 Category: General Medicine Authors: Maribel Salas Maxine Gossell-Williams Priyanka Yalamanchili Sameer Dhingra Marina A Malikova Omar Aimer Toluwalope Junaid Source Type: research
The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
CONCLUSION: Various categories of biomarkers including safety, predictive, pharmacodynamic/response, and diagnostic biomarkers are being investigated for potential use in pharmacovigilance. The most frequent potential uses of biomarkers in pharmacovigilance in the literature were the prediction of the severity of an ADR, mortality, response, safety, and toxicity. The safety biomarkers identified were used to evaluate patient safety during dose escalation, identify patients who may benefit from further biomarker testing during treatment, and monitor ADRs.PMID:37077840 | PMC:PMC10108426 | DOI:10.1177/11772719231164528 (Sourc...
Source: Biomarker Insights - April 20, 2023 Category: General Medicine Authors: Maribel Salas Maxine Gossell-Williams Priyanka Yalamanchili Sameer Dhingra Marina A Malikova Omar Aimer Toluwalope Junaid Source Type: research
The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
CONCLUSION: Various categories of biomarkers including safety, predictive, pharmacodynamic/response, and diagnostic biomarkers are being investigated for potential use in pharmacovigilance. The most frequent potential uses of biomarkers in pharmacovigilance in the literature were the prediction of the severity of an ADR, mortality, response, safety, and toxicity. The safety biomarkers identified were used to evaluate patient safety during dose escalation, identify patients who may benefit from further biomarker testing during treatment, and monitor ADRs.PMID:37077840 | PMC:PMC10108426 | DOI:10.1177/11772719231164528 (Sourc...
Source: Biomarker Insights - April 20, 2023 Category: General Medicine Authors: Maribel Salas Maxine Gossell-Williams Priyanka Yalamanchili Sameer Dhingra Marina A Malikova Omar Aimer Toluwalope Junaid Source Type: research
The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
CONCLUSION: Various categories of biomarkers including safety, predictive, pharmacodynamic/response, and diagnostic biomarkers are being investigated for potential use in pharmacovigilance. The most frequent potential uses of biomarkers in pharmacovigilance in the literature were the prediction of the severity of an ADR, mortality, response, safety, and toxicity. The safety biomarkers identified were used to evaluate patient safety during dose escalation, identify patients who may benefit from further biomarker testing during treatment, and monitor ADRs.PMID:37077840 | PMC:PMC10108426 | DOI:10.1177/11772719231164528 (Sourc...
Source: Biomarker Insights - April 15, 2023 Category: General Medicine Authors: Maribel Salas Maxine Gossell-Williams Priyanka Yalamanchili Sameer Dhingra Marina A Malikova Omar Aimer Toluwalope Junaid Source Type: research
The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
CONCLUSION: Various categories of biomarkers including safety, predictive, pharmacodynamic/response, and diagnostic biomarkers are being investigated for potential use in pharmacovigilance. The most frequent potential uses of biomarkers in pharmacovigilance in the literature were the prediction of the severity of an ADR, mortality, response, safety, and toxicity. The safety biomarkers identified were used to evaluate patient safety during dose escalation, identify patients who may benefit from further biomarker testing during treatment, and monitor ADRs.PMID:37077840 | PMC:PMC10108426 | DOI:10.1177/11772719231164528 (Sourc...
Source: Biomarker Insights - April 15, 2023 Category: General Medicine Authors: Maribel Salas Maxine Gossell-Williams Priyanka Yalamanchili Sameer Dhingra Marina A Malikova Omar Aimer Toluwalope Junaid Source Type: research
The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature
CONCLUSION: Various categories of biomarkers including safety, predictive, pharmacodynamic/response, and diagnostic biomarkers are being investigated for potential use in pharmacovigilance. The most frequent potential uses of biomarkers in pharmacovigilance in the literature were the prediction of the severity of an ADR, mortality, response, safety, and toxicity. The safety biomarkers identified were used to evaluate patient safety during dose escalation, identify patients who may benefit from further biomarker testing during treatment, and monitor ADRs.PMID:37077840 | PMC:PMC10108426 | DOI:10.1177/11772719231164528 (Sourc...
Source: Biomarker Insights - April 15, 2023 Category: General Medicine Authors: Maribel Salas Maxine Gossell-Williams Priyanka Yalamanchili Sameer Dhingra Marina A Malikova Omar Aimer Toluwalope Junaid Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
